These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8510320)

  • 61. [Epidemiological studies on drug-resistance patterns, coagulase types, and MRSA-phage types of MRSA isolates during 1990-1994].
    Nakae M; Sugahara Y; Sasaki H; Yasui H; Imai C; Hasegawa Y; Osaka K; Sibasaki K; Nashimoto M
    Jpn J Antibiot; 1999 Apr; 52(4):313-21. PubMed ID: 10396688
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Usefulness of PCR-restriction fragment length polymorphism typing of the coagulase gene to discriminate arbekacin-resistant methicillin-resistant Staphylococcus aureus strains.
    Ishino K; Tsuchizaki N; Ishikawa J; Hotta K
    J Clin Microbiol; 2007 Feb; 45(2):607-9. PubMed ID: 17166956
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Epidemiological survey of methicillin-resistant Staphylococcus aureus isolated from 34 hospitals in Japan].
    Ida T; Nonoyama M; Hasobe T; Shimauchi C; Inoue M; Okamoto R
    Jpn J Antibiot; 1994 Jun; 47(6):585-94. PubMed ID: 8072166
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus.
    Kondo S; Tamura A; Gomi S; Ikeda Y; Takeuchi T; Mitsuhashi S
    J Antibiot (Tokyo); 1993 Feb; 46(2):310-5. PubMed ID: 8468247
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Sensitivity of MRSA isolated in our hospital to various antibacterial agents: changes over 5 years].
    Shiotani J; Takehana K
    Jpn J Antibiot; 2004 Apr; 57(2):196-203. PubMed ID: 15224661
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [A survey of Staphylococcus aureus for typing and drug-resistance in various areas of Japan during 1992 and 1993].
    Hashimoto H; Inoue M; Hayashi I
    Jpn J Antibiot; 1994 Jun; 47(6):618-26. PubMed ID: 8072169
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical laboratory approach to evaluate administration dose of arbekacin. Reevaluation of in vitro MIC break points in the disk susceptibility test].
    Matsuo K; Uete T
    Jpn J Antibiot; 1994 Aug; 47(8):1041-52. PubMed ID: 7933533
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synergistic effect of fosfomycin and arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model.
    Morikawa K; Nonaka M; Yoshikawa Y; Torii I
    Int J Antimicrob Agents; 2005 Jan; 25(1):44-50. PubMed ID: 15620825
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cross-resistance of clinical isolates of methicillin-resistant Staphylococcus aureus to aminoglycosides and fluoroquinolones.
    Uete T; Matsuo K; Uete G
    Jpn J Antibiot; 1992 Aug; 45(8):943-8. PubMed ID: 1433900
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
    Tsuji A; Sugano T; Yamaguchi K; Goto S; Takada T; Takase Y; Yoshida T
    Jpn J Antibiot; 1994 Jun; 47(6):655-63. PubMed ID: 8072174
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [MRSA infections in surgery].
    Fujita K; Suzuki T; Kato H; Nagamachi Y; Okubo T
    Jpn J Antibiot; 1994 Jun; 47(6):813-9. PubMed ID: 8072191
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Antibacterial activities of various aminoglycosides against clinically isolated methicillin-resistant Staphylococcus aureus].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Sato K; Kato M
    Jpn J Antibiot; 1987 Nov; 40(11):1941-5. PubMed ID: 3444031
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Effective single and combined chemotherapeutic regimens as regards to antibiotic resistance patterns of methicillin-resistant Staphylococcus aureus (MRSA) in Japan].
    Watanabe A
    Nihon Rinsho; 1992 May; 50(5):1060-5. PubMed ID: 1507429
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
    Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [In vitro activity of arbekacin against clinical isolates of Staphylococcus species and gram-negative bacilli].
    Lee J; Kim CK; Roh KH; Lee H; Yum JH; Yong D; Lee K; Chong Y
    Korean J Lab Med; 2007 Aug; 27(4):292-7. PubMed ID: 18094591
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1991). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Oct; 48(10):1394-421. PubMed ID: 8544337
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Blepharismin produced by a protozoan Blepharisma functions as an antibiotic effective against methicillin-resistant Staphylococcus aureus.
    Pant B; Kato Y; Kumagai T; Matsuoka T; Sugiyama M
    FEMS Microbiol Lett; 1997 Oct; 155(1):67-71. PubMed ID: 9345766
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Staggered intensive chemotherapy using arbekacin, fosfomycin and ceftazidime on polymicrobial infections involving MRSA].
    Tanaka T; Iida-Tanaka K; Takahara J; Fujioka Y; Tamura T; Yamanoi Y; Houjou S; Takahashi T; Miki S; Nakamura Y
    Jpn J Antibiot; 1994 Jun; 47(6):790-7. PubMed ID: 8072188
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Methicillin-resistant Staphylococcus aureus (MRSA) isolated at Fukuoka University Hospital and hospitals and clinics in the Fukuoka city area.
    Takeda S; Yasunaka K; Kono K; Arakawa K
    Int J Antimicrob Agents; 2000 Feb; 14(1):39-43. PubMed ID: 10717499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.